Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;
First, heavy! Shanghai merger and reorganization action plan announcedGuoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;China Research Institute: Wang Xiuyun reduced its shareholding by 1%. At present, the company has not directly involved in the application field of humanoid robots.
Haineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%;Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.News:
Strategy guide 12-14
Strategy guide 12-14